The online portal ALZFORUM has published an in-depth article on the novel D-peptide based therapeutic approach against Alzheimer's disease, which has been developed by scientists led by Dieter Willbold at Forschungszentrum Jülich and Heinrich Heine University Düsseldorf and is currently on its way to Phase 1 Trials in humans.

The article is based on results recently reported at the 12. International Conference on Alzheimer's and Parkinson's diseases in Nice.

Link: D-peptides as Drugs? Protein Therapy Approaching Phase 1 Trials